Current clinical evidence in ophthalmology [E-Book]

Includes index.

Online resource; title from PDF title page (EBSCO, January 11, 2019).

Intro; Introduction; Preface; About the authors; List of Abbreviations; Anterior Segment; Herpetic Eye Disease Study -- 1 (HEDS -- 1); Herpetic Eye Disease Study -- 2 (HEDS -- 2); Endophthalmitis Vitrectomy Study (EVS); European Society for Cataract and RefractiveSurgeons (ESCRS Study); Collaborative Longitudinal Evaluation ofKeratoconus (CLEK); Corneal collagen cross-linking in progressivekeratoconus; Glaucoma; Ocular Hypertension Treatment Study (OHTS); European Glaucoma Prevention Study (EGPS); Early Manifest Glaucoma Trial (EMGT); United Kingdom Glaucoma Treatment Study(UKGTS).

Advanced Glaucoma Intervention Study (AGIS)Collaborative Initial Glaucoma Treatment Study (CIGTS); Collaborative Normal-Tension Glaucoma Study(CNTGS); Low-Tension Glaucoma Treatment Study (LoGTS); Glaucoma Laser Trial (GLT); 5-Fluorouracil Filtering Surgery Study (FFSS); Tube Versus Trabeculectomy (TVT) study; Ahmed Baerveldt Comparison (ABC) and AhmedVersus Baerveldt (AVB) Studies; Effectiveness in Angle-closure Glaucoma of LensExtraction (EAGLE) Study; Retina; Diabetic Control and Complication Trial (DCCT)and Epidemiology of Diabetes Interventions andComplications (EDIC) trial.

United Kingdom Prospective Diabetes Study (UKPDS)Diabetic Retinopathy Study (DRS); Early Treatment of Diabetic Retinopathy Study (ETDRS); DRCR.NET Protocol I -- Macular Laser Combinedwith Ranibizumab or Triamcinalone vs. MacularLaser Alone; DRCR.NET Protocol T -- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema; DRCR.NET Protocol S -- PanretinalPhotocoagulation vs. Intravitreal Ranibizumab forProliferative Diabetic Retinopathy; Fenofibrate Intervention and Event Lowering inDiabetes (FIELD); Diabetic Retinopathy Vitrectomy Study (DRVS).

Ranibizumab for Diabetic Macular Oedema (RISE & RIDE)Ranibizumab Monotherapy or Combined with Laserversus Laser Monotherapy for Diabetic MacularEdema (RESTORE); Intravitreal Aflibercept for Diabetic Macular Edema(DA VINCI); Intravitreal Aflibercept for Diabetic Macular Edema (VIVID & VISTA); Bevacizumab or Laser Therapy in the Managementof Diabetic Macular Edema (BOLT); Fluocinolone Acetonide Vitreous Inserts forDiabetic Macular Edema (FAME A & B); The Age-Related Eye Disease Study (AREDS I).

Lutein, Zeaxanthin and Omega-3 Fatty Acids forAge-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS-2)Ranibizumab vs. Verteporfin for PredominantlyClassic Choroidal Neovascularisation in Age-Related Macular Degeneration (ANCHOR); Ranibizumab for Minimally Classic or OccultNeovascular Age-Related Macular Degeneration (MARINA); Randomised, Double-Masked, Sham-ControlledTrial of Ranibizumab for Neovascular Age-relatedMacular Degeneration (PIER); Safety and Efficacy of a Flexible Dosing Regimen ofRanibizumab in Neovascular Age-Related MacularDegeneration (SUSTAIN).

Master record variable field(s) change: 072, 082